Results 71 to 80 of about 315,994 (289)

Rheumatoid Factors: Clinical Applications [PDF]

open access: yesDisease Markers, 2013
Rheumatoid factors are antibodies directed against the Fc region of immunoglobulin G. First detected in patients with rheumatoid arthritis 70 years ago, they can also be found in patients with other autoimmune and nonautoimmune conditions, as well as in healthy subjects.
Francesca Ingegnoli   +2 more
openaire   +5 more sources

c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases. [PDF]

open access: yes, 2012
The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase (MAPK) family and are activated by environmental stress. JNK is also activated by proinflammatory cytokines, such as TNF and IL-1, and Toll-like receptor ligands ...
Firestein, Gary S, Guma, Monica
core   +1 more source

Patient Perceptions of Medication Therapy for Prevention of Posttraumatic Osteoarthritis Following Anterior Cruciate Ligament Injury: A Qualitative Content Analysis

open access: yesArthritis Care &Research, EarlyView.
Objective Posttraumatic osteoarthritis (PTOA) accounts for nearly 12% of osteoarthritis incidences and often occurs after anterior cruciate ligament (ACL) tear. Ensuring the uptake of preventive treatments for PTOA requires that investigators and clinicians understand factors influencing patients to seek preventive therapies.
Lily M. Waddell   +10 more
wiley   +1 more source

Diagnostic value of simultaneous use of anti-cyclic citrulinated peptide and rheumatoid factor in rheumatoid arthritis

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2013
Background and Objective: Rheumatoid arthritis (RA) is a systemic and chronic disease. Anticitrulinated anticyclic antibody (Anti-CCP) and rheumatoid factor (RF) are applied for the diagnosis of rheumatoid arthritis.
Azarhoush R, Aghaii M
doaj  

Employing Feature Selection Algorithms to Determine the Immune State of a Mouse Model of Rheumatoid Arthritis [PDF]

open access: yesarXiv, 2022
The immune response is a dynamic process by which the body determines whether an antigen is self or nonself. The state of this dynamic process is defined by the relative balance and population of inflammatory and regulatory actors which comprise this decision making process. The goal of immunotherapy as applied to, e.g. Rheumatoid Arthritis (RA), then,
arxiv  

Autologous Agglutinators to Erythrocytes Sensitized with the Ripley Anti-Rh Antibody Digested with 14 Different Proteolytic Enzymes [PDF]

open access: yes, 1967
Studies with 14 different enzyme digested globulin preparations of a single anti-Rh serum Ripley has revealed an astonishing array of autoagglutinators to his enzymatically degraded anti-Rh antibodies.
Waller, Marion
core   +1 more source

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe. [PDF]

open access: yes, 2009
Contains fulltext : 80544.pdf (publisher's version ) (Closed ...
Choy, E.   +11 more
core   +1 more source

Sex‐Related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta‐Analysis

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to assess differences in baseline characteristics, efficacy, and safety of advanced therapies between male and female patients with axial spondyloarthritis (axSpA) in randomized controlled trials (RCTs). Methods We conducted a systematic literature search for RCTs assessing the efficacy of advanced therapies in patients with axSpA ...
Angel Gao   +5 more
wiley   +1 more source

Musculoskeletal Sarcoidosis and Rheumatoid Factor [PDF]

open access: yes, 1972
Articular manifestations of sarcoidosis were present in 19 of our 60 patients (32%). This correlates with previously reported studies. In all of our cases but one, the articular manifestations subsided in eight weeks.
Owen, Duncan S., Jr.   +3 more
core   +1 more source

Persistencia de medicamentos biológicos durante ocho años en pacientes con artritis reumatoide y espondiloartritis [PDF]

open access: yes, 2019
Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare ...
Balsa, Alejandro   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy